Elm Street Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2

- Investments
-
39
- Portfolio
-
13
- Exits
-
17

Elm Street Ventures General Information
Description
Founded in 2006, Elm Street Ventures is a venture capital firm based in New Haven, Connecticut. The firm seeks to invest in companies operating in the life science, therapeutic, laboratory tools, diagnostic, medical device, green technology, software, healthcare, mobile, healthcare service, clean technology, material, sustainable technology and information technology sectors.
Contact Information
Website
www.elmvc.com
Year Founded
2006
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Primary Office
- 33 Whitney Avenue
- New Haven, CT 06510
- United States
+1 (203) 000-0000
Elm Street Ventures Investments (39)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
P2 Science | 23-Feb-2023 | Later Stage VC | 0000 | Specialty Chemicals | Generating Revenue | |
00 0000000 | 18-Nov-2022 | 00000 00000 | 00.000 | Specialty Chemicals | Generating Revenue | |
0000000 0000000000 | 24-Jun-2022 | 00000 00000 | 000.00 | Drug Delivery | Clinical Trials - Phase 2 | |
0000000 0000000000 | 15-Jun-2022 | 00000 00000 | 000.00 | Drug Discovery | Pre-Clinical Trials | |
00000000 000000000 | 01-Dec-2021 | 00000 00000 | Biotechnology | Generating Revenue | 00000000000 000000 | |
000000 00000000000 | 16-Nov-2021 | 00000 00000 | 000.00 | Discovery Tools (Healthcare) | Product Development | 0000000 0000 |
00000 000000000000 | 01-Jun-2021 | 00000 00000 | 00.000 | Drug Discovery | Clinical Trials - Phase 1 | 000000 000000000 |
00000 000000000000 | 11-Mar-2021 | 0000 00000 | 00000 | Drug Discovery | Generating Revenue | 0000000 0000 |
CellFE | 31-Mar-2020 | Seed Round | 00.00 | Biotechnology | Generating Revenue | 00000000000 000000 |
EvolveImmune Therapeutics | 13-Jan-2020 | Early Stage VC | 0000 | Drug Discovery | Generating Revenue |
Elm Street Ventures Exits (17)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Iconic Therapeutics | 01-Jun-2022 | Merger/Acquisition | |
000000 | 01-Jul-2021 | 000000000 00000000 | |
00000000000 | 11-Oct-2019 | 0000000000 | |
00000000 | 01-Feb-2019 | 00 000000000000000 | 0000 |
0000000 | 27-Sep-2018 | 000 | 00000 |
0000000 0000000000 | 29-Nov-2016 | 000000000000000000 | 00000 |
000000 00000000000 | 01-Apr-2016 | 000 00 00000000 | |
00000 00000000 | 01-Jan-2016 | 000000000 00000000 | |
AxioMx | 11-Nov-2015 | Merger/Acquisition | 000.00 |
Metagenomix | 01-Mar-2015 | Out of Business |
Elm Street Ventures Investments by Industry, Year, and Region
Elm Street Ventures Team (19)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Robert Bettigole | Founder & Managing Partner | 0 | 0 | 0 | New Haven, CT |
Christopher McLeod | Managing Partner | 0 | 0 | 0 | New Haven, CT |
David Whittaker MD | Venture Partner | 0 | 0 | 0 | New Haven, CT |
Rick Stahl MD | Venture Partner | New Haven, CT | |||
David Hathaway | Advisor | 00 | 0 | New Haven, CT |
Elm Street Ventures Co-Investors (37)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Connecticut Innovations | 5 | 0 |
![]() |
![]() |
|
Advantage Capital (Saint Louis) | 0 |
![]() |
![]() |
||
Canaan Partners | 0 | 0 |
![]() |
![]() |
|
Ironwood Capital | 0 |
![]() |
![]() |
||
Johnson & Johnson Innovation - JJDC | 0 | 0 |
![]() |
![]() |